Company: LCTX
Filing Date: 2025-08-26
Form Type: 8-K
Source: 0000950170-25-111319
Chunk: 2

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-08-26
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                  
         99.1      Press release issued on August 26, 2025                                      
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                              Lineage Cell Therapeutics, Inc.          
  Date:      August 26, 2025      By:         /s/ George A. Samuel III                 
                                  Name:       George A. Samuel III